ViSalus

Troy, United States Founded: 2005 • Age: 21 yrs Acquired By Blyth
Direct seller of nutritional supplements, energy drinks and weight management products

About ViSalus

ViSalus is a Healthcare company based in Troy (United States) founded in 2005, and was acquired by Blyth in August 2008. Direct seller of nutritional supplements, energy drinks and weight management products. ViSalus has raised $6.41 million across 2 funding rounds from investors including Blyth. The company has 486 employees. The company was acqui-hired. Its focus areas include Life Sciences, Nutraceuticals Tech, Supplements and Multicategory. Its legal entity is VISALUS, INC. Its competitors include Carson Life, Mead johnson and Balchem; 1 of its 3 listed competitors has raised funding.

Company details

ViSalus is a direct seller of nutritional supplements, energy drinks and weight management products. It offers weight management products, including Vi-Trim, an appetite-suppressant drink mix; nutritional cookies; Vi-Shape, a meal replacement shake to promote weight loss through health flavor mix-in system; and Vi-Slim Metab-Awake tablets that are metabolism supporting tablets. It also provides various kits for the consumers such as Weight loss kit, lifestyle kit, fitness kit. The company was founded in 2005 and got acquired by Blyth Inc. in 2012. Bryant Park Capital served as financial advisor in connection with this transaction.

  • Headquarters Troy, United States
  • Employees 486
  • Stage Acquired
  • Sectors
    Healthcare
  • Website visalus.com
  • Social LinkedIn X Facebook
  • Acquired by Blyth (Aug 2008)
  • Legal Name Visalus, Inc.
Key Metrics
  • Total Equity Funding
    $6.41M (USD)

    in 2 rounds

  • Latest Funding Round
    $6.41M (USD), Series A

    May 2016

  • Investors
  • Employee Count
    486
  • Acquired by
    Blyth

    (Aug 2008)

Funding Insights of ViSalus

ViSalus has successfully raised a total of $6.41M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.41 million completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $6.41M
  • Total Rounds 2
  • Last Round Series A β€” $6.41M
  • First Round $6.41M

    (Feb 2016)

All 2 funding rounds of ViSalus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2016$6.41MSeries A––
–
Feb 2016$6.41MDebt – Conventional––
–
Valuation history

1 investors in total: 1 institutional.

Investors in ViSalus

ViSalus has secured backing from 1 investor. Prominent investors backing the company include Blyth.

All
InvestorDescriptionFounded YearDomainLocation
Limited information available
1977blyth.comGreenwich, United States
Premium access

Investor details for ViSalus

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of ViSalus

4 dated milestones of ViSalus across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded ViSalus is founded.
  2. Exit Acquired by Blyth.
  3. Funding First funding round of $6.4M.
  4. Funding Latest funding round, Series A, of $6.4M.

Competitors of ViSalus

ViSalus has 3 listed competitors in our database, 1 of them funded. They include Carson Life, Mead johnson and Balchem.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
carsonlife.com2014Miami, United States$5.44M
Natural health and beauty products are manufactured in various categories.
meadjohnson.com1900Chicago, United States570
Infant nutrition products are manufactured and marketed by Mead Johnson.
balchem.com1967New Hampton, United States2,293
Nutraceutical ingredients are manufactured for human and animal nutrition products.
Premium access

Detailed competitors of ViSalus

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of ViSalus

Websites that share an audience with ViSalus (visalus.com).

Similar websites

Websites whose visitors overlap most with ViSalus. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
youngandraw.com
youngandraw.com
100%
–
lazymanandmoney.com
lazymanandmoney.com
69%
#3,521,600–
myvi.net
myvi.net
42%
–
bodybyvi.com
bodybyvi.com
41%
#1,791,158–

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as ViSalus (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapies for metabolic health in chronic disease patients are provided.
2014San Francisco, California, United StatesUSD 401.78 M910
Personalized gut health solutions are provided by ZOE.
2017New Castle, Pennsylvania, United StatesUSD 15 M
Machine learning-based bioinformatics solutions for health insights are provided.
2016Los Alamos, New Mexico, United StatesUSD 301.57 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Visalus

Premium access

Complete news archive for ViSalus

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ViSalus

ViSalus was founded in 2005 and raised its 1st funding round 11 years after it was founded.

ViSalus is headquartered in Troy, United States.

ViSalus is a funded company, having raised a total of $6.41M across 2 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $6.41M, raised on Feb 2016.

ViSalus has 486 employees.

ViSalus is a direct seller of nutritional supplements, energy drinks and weight management products. It offers weight management products, including Vi-Trim, an appetite-suppressant drink mix; nutritional cookies; Vi-Shape, a meal replacement shake to promote weight loss through health flavor mix-in system; and Vi-Slim Metab-Awake tablets that are metabolism supporting tablets. It also provides various kits for the consumers such as Weight loss kit, lifestyle kit, fitness kit. The company was founded in 2005 and got acquired by Blyth Inc. in 2012. Bryant Park Capital served as financial advisor in connection with this transaction.

ViSalus's top competitors include Mead johnson, Balchem and Carson Life.

ViSalus has 1 investor. Key investors include Blyth.

ViSalus operates through Visalus, Inc..

Yes. ViSalus was acquired by Blyth in August 2008.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available